monoclonal antibodies

Wilmington, Delaware, United States, July 17, 2023 (GLOBE NEWSWIRE) -- The global antibody production market is projected to flourish at a CAGR of 7.8% from 2021 to 2031. As per the report published by TMR, a valuation of US$ 30.7…

Wilmington, Delaware, United States, June 13, 2023 (GLOBE NEWSWIRE) -- The global cancer biologics market was valued at US$ 94.5 Bn in 2022. It is projected to expand at a CAGR of 7.7% from 2023 to 2031. Significant demand for monoclonal…

<!-- Name:DistributionId Value:8839512 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:5557 -->…

<!-- Name:DistributionId Value:8837041 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

<!-- Name:DistributionId Value:8793208 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

<!-- Name:DistributionId Value:8754497 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…

Selbyville, Delaware, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The bioreactors market value is anticipated to garner over USD 28 billion by 2032, according to the recent research report by Global Market Insights Inc.  Increasing demand for…

JUPITER, Fla., July 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and deploying its…

New York, United States, June 23, 2022 (GLOBE NEWSWIRE) -- The market for biologics is growing steadily because companies are spending a lot of money to improve the places where they make their products. Biologics can be used in many…

Selbyville, Delaware , June 01, 2022 (GLOBE NEWSWIRE) -- The bioreactors market value is projected to reach USD 23 billion by 2030, according to a new research report by Global Market Insights Inc. Booming pharmaceuticals and…